Cyclic Glycine-Proline and Tesamorelin Interaction

Monitor
Mechanism-based 47% confidence

Cyclic Glycine-Proline and Tesamorelin have an interaction requiring monitoring for interaction with 47% confidence. Both Cyclic Glycine-Proline and Tesamorelin affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). These compounds primarily affect different organ systems.

Compound Profiles

Cyclic Glycine-Proline

IGF-1 Bioavailability Regulator & Neuroprotective Peptide

Competes with IGF-1 for IGFBP-3 binding, normalizing bioavailable IGF-1 levels. Acts as positive allosteric modulator of AMPA and GABA-A receptors.

Half-life: Extended stability (more stable than linear GPE precursor) Typical dose: 20-100 μg daily (or 300mg blackcurrant extract 2x daily) cognitive, longevity
bdnfgabaigf1 insulin disrupting
View full profile

Tesamorelin

GHRH Analog | Visceral Fat Reduction

Subcutaneous injection provides optimal bioavailability for GHRH receptor binding and pulsatile GH release stimulation, selectively targeting visceral adipose tissue while sparing subcutaneous fat..

Half-life: 26-38 minutes Typical dose: 1.4-2mg daily (FDA-approved: 2mg for HIV lipodystrophy) growth hormone, weight loss
ghrh receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

Brain
low
GI Tract
low
Pituitary
low

Shared Safety Flags

2x 2 compounds affect insulin sensitivity (Cyclic Glycine-Proline, Tesamorelin). Monitor fasting glucose and HbA1c.

Frequently Asked Questions

Can I take Cyclic Glycine-Proline with Tesamorelin?

Yes, but with caution. Both Cyclic Glycine-Proline and Tesamorelin affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). Regular monitoring is advised.

Is Cyclic Glycine-Proline and Tesamorelin safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: insulin disrupting. Monitor accordingly.

What are the interactions between Cyclic Glycine-Proline and Tesamorelin?

Both Cyclic Glycine-Proline and Tesamorelin affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time Cyclic Glycine-Proline and Tesamorelin?

Cyclic Glycine-Proline has a half-life of Extended stability (more stable than linear GPE precursor) and Tesamorelin has a half-life of 26-38 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Cyclic Glycine-Proline vs Tesamorelin

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.